More
    Guided Solutions - Connecting Talent With Innovation/div>

    Pantheon meets with FDA to discuss PMA submission for corneal implants

    Pantheon Vision has completed two pre-submission meetings with the US Food and Drug Administration (FDA) as the company looks to advance its corneal implants...

    FDA approves Lumicell’s breast cancer visualization system

    Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal. According to the company, the LumiSystem allows surgeons...

    FDA approves XStim spine fusion stimulator

    Xstim announced today that it received premarket approval from the FDA for its Xstim spine fusion stimulator device.Irving, Texas-based Xstim designed its capacitively coupled...

    Adherium’s Smartinhaler gains clearance for use with AstraZeneca devices

    Adherium has obtained US Food and Drug Administration (FDA) clearance for the use of its Hailie Smartinhaler with AstraZeneca’s Airsupra and Breztri inhalation devices. This...

    IceCure submits final breast cancer cryoablation data to FDA

    IceCure Medical announced it submitted final data to the FDA requesting marketing authorization for its ProSense system. Caesarea, Israel-based IceCure designed ProSense to deliver...

    Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants

    Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that...

    FDA issues 510(k) clearance for twiist insulin system

    DEKA Research & Development has received 510(k) clearance from the US Food and Drug Administration (FDA) for the twiist automated insulin delivery (AID) system. The...

    FDA clears first over-the-counter wearable glucose tracker, with Dexcom’s Stelo

    The FDA has cleared its first over-the-counter wearable blood sugar tracker, with Dexcom’s slimmed-down Stelo continuous glucose monitor. Related: Orthobond wins FDA de novo approval...

    Orthobond wins FDA de novo approval for antibacterial technology that could have vast device applications

    Orthobond has secured FDA de novo approval for its Ostaguard antibacterial technology that could one day be used for a wide range of medical...

    Latest articles